| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal HST29:Velmanase alfa for treating alpha-mannosidosis |
|
Medicine details |
|
| Medicine name | velmanase alfa (Lamzede®) |
| Formulation | 10 mg powder for solution for infusion |
| Reference number | 2291 |
| Indication | Enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis |
| Company | Chiesi Ltd |
| BNF chapter | Nutrition & blood |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 08/02/2018 |
| NICE guidance | |